Identification of a Two-Gene (PML-EPB41) Signature With Independent Prognostic Value in Osteosarcoma
Conclusion: Our findings define novel biomarkers for OSA prognosis, which will possibly aid in the discovery of novel therapeutic targets with clinical applications.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Bone Cancers | Cancer | Cancer & Oncology | Cancer in Adolescents | Children | Databases & Libraries | Genetics | Molecular Biology | Osteosarcoma